3 Steps for cell & gene therapy medical affairs teams to provide strategic value
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success,...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Kaitlyn is a vice president in the Life Sciences Practice of CRA. She has 15 years’ experience in HCP and patient insights, leveraging primary market research, secondary research and claims analytics to inform biopharmaceutical company strategies.
In her 7+ years at CRA, Kaitlyn has developed an expertise in oncology, women’s health, mental health, and rare disease including gene therapies. Kaitlyn specifically has helped commercial and medical affairs clients conduct patient journeys, opportunity assessments, segmentations, forecasting, assess business model & launch plans and conduct patient finding exercises. She is also an experienced moderator for market research as well as workshops, utilizing innovative methodologies to help companies unlock insights as well as align on strategies to optimize launch positioning, messaging, tactics and KPIs.